BALVERSA cpr pell 3 mg bte 56 pce

7680676600013 CH-67660 L01EN01 07.16.1.

Reimbursement limitations:

BALVERSA

Après garantie de prise en charge des coûts par l’assureur-maladie après consultation du médecin-conseil.

BALVERSA cpr pell 3 mg bte 56 pce
BALVERSA cpr pell 3 mg bte 56 pce
BALVERSA cpr pell 3 mg bte 56 pce
1 / 3
google

Details

Product number
6766001
CPT
-
Packaging group
56
Unit
Tablette(n)
Composition
erdafitinibum 3 mg, mannitolum, cellulosum microcristallinum, megluminum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, E 172 (flavum), glyceroli monocaprylocapras, natrii laurilsulfas, pro compresso obducto corresp. natrium 0.329 mg.

Articles (1)

Balversa 3 mg, Filmtabletten
Filmtabletten
56
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/04/2025
Patient information leaflet
Français
22/04/2025
Patient information leaflet
Italien
22/04/2025
Professional SmPC
Allemand
22/04/2025
Professional SmPC
Français
22/04/2025
Professional SmPC
Italien
22/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.329 MG Substance HBESI

Reimbursement information

Public price
CHF 10020.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2025

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
67660
Drug name
Balversa, Filmtabletten
Galenic form
FILM
ATC Code
L01EN01
Authorization status
Z
Dispensation category
A
First authorization
14/01/2025
Authorization expiration date
13/01/2030
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung erwachsener Patienten mit Urothelkarzinom (UC)

Packaging details

Description (FR)
BALVERSA cpr pell 3 mg bte 56 pce
Description (DE)
BALVERSA Filmtabl 3 mg Ds 56 Stk
Market launch
14/01/2025
Narcotic (BTM)
No

Other packaging sizes

BALVERSA cpr pell 3 mg bte 84 pce
84 TABL
View
BALVERSA cpr pell 4 mg bte 28 pce
28 TABL
View
BALVERSA cpr pell 4 mg bte 56 pce
56 TABL
View
BALVERSA cpr pell 5 mg bte 28 pce
28 TABL
View